Global Imaging Biomarkers Market Size & Outlook, 2025-2033

The global imaging biomarkers market size was estimated at USD 13,950.0 million in 2024 and is projected to reach USD 39,227.5 million by 2033, growing at a CAGR of 12.6% from 2025 to 2033.
Revenue, 2024 (US$M)
$13,950.0
Forecast, 2033 (US$M)
$39,227.5
CAGR, 2025 - 2033
12.6%
Report Coverage
Worldwide

Global imaging biomarkers market, 2021-2033 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Global imaging biomarkers market highlights

  • The global imaging biomarkers market generated a revenue of USD 13,950.0 million in 2024 and is expected to reach USD 39,227.5 million by 2033.
  • The market is expected to grow at a CAGR (2025 - 2033) of 12.6% by 2033.
  • In terms of segment, molecular/nuclear biomarkers accounted for a revenue of USD 5,214.0 million in 2024.
  • Quantitative Imaging Biomarkers is the most lucrative biomarkers segment registering the fastest growth during the forecast period.
  • In terms of region, North America was the largest revenue generating market in 2024.
  • Country-wise, China is expected to register the highest CAGR from 2025 to 2033.

Global data book summary

Market revenue in 2024USD 13,950.0 million
Market revenue in 2033USD 39,227.5 million
Growth rate12.6% (CAGR from 2025 to 2033)
Largest segmentMolecular/nuclear biomarkers
Fastest growing segmentQuantitative Imaging Biomarkers
Historical data covered2021 - 2023
Base year for estimation2024
Forecast period covered2025 - 2033
Quantitative unitsRevenue in USD million
Market segmentationAnatomical Biomarkers, Functional Biomarkers, Molecular/Nuclear Biomarkers, Quantitative Imaging Biomarkers

Other key industry trends

  • In terms of revenue, the North America accounted for 32.9% of the global imaging biomarkers market in 2024.
  • By country, the U.S. is projected to lead the global market in terms of revenue in 2033.
  • By country, China is the fastest growing regional market and is projected to reach USD 3,826.7 million by 2033.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Imaging Biomarkers Market Companies

Name Profile # Employees HQ Website
F. Hoffmann-La Roche AG View profile - - -
PerkinElmer, Inc. View profile - - -
Bio-Rad Laboratories, Inc. View profile - - -
IXICO PLC View profile 83 15 Long Lane, 4th Floor, Griffin Court, London, United Kingdom, EC1A 9PN https://www.ixico.com
Median Technologies View profile 101-250 Valbonne, Provence-Alpes-Cote d'Azur, France, Europe http://www.mediantechnologies.com
Brainomix View profile 11-50 Oxford, Oxfordshire, United Kingdom, Europe http://www.brainomix.com
Hologic Inc View profile 6990 250 Campus Drive, Marlborough, MA, United States, 01752 http://www.hologic.com
Qiagen NV View profile 5900 Hulsterweg 82, Venlo, LI, Netherlands, 5912 PL https://www.qiagen.com
Thermo Fisher Scientific Inc View profile 122000 168 Third Avenue, Waltham, MA, United States, 02451 https://www.thermofisher.com
Siemens Healthineers AG ADR View profile 71400 Siemensstr. 3, Forchheim, BY, Germany, 91301 https://www.siemens-healthineers.com
Abbott Laboratories View profile 114000 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 https://www.abbottinvestor.com

Global imaging biomarkers market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to imaging biomarkers market will help companies and investors design strategic landscapes.


Molecular/nuclear biomarkers was the largest segment with a revenue share of 37.38% in 2024. Horizon Databook has segmented the Global imaging biomarkers market based on anatomical biomarkers, functional biomarkers, molecular/nuclear biomarkers, quantitative imaging biomarkers covering the revenue growth of each sub-segment from 2021 to 2033.


  • Global Imaging Biomarkers Biomarkers Outlook (Revenue, USD Million, 2021-2033)
    • Anatomical Biomarkers
    • Functional Biomarkers
    • Molecular/Nuclear Biomarkers
    • Quantitative Imaging Biomarkers
    • Others
  • Global Imaging Biomarkers Application Outlook (Revenue, USD Million, 2021-2033)
    • Diagnostics
    • Drug Discovery & Development
    • Personalized Medicine
    • Disease Risk Assessment
    • Others
  • Global Imaging Biomarkers Technology Outlook (Revenue, USD Million, 2021-2033)
    • MRI
    • CT
    • PET
    • SPECT
    • Ultrasound
    • Others ( Microfluidics and Lab-on-a-Chip Platforms )
  • Global Imaging Biomarkers End Use Outlook (Revenue, USD Million, 2021-2033)
    • Hospitals
    • Diagnostic/imaging centers
    • Pharmaceutical and Biotech Companies
    • Others

Reasons to subscribe to Global imaging biomarkers market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Global imaging biomarkers market databook

  • Our clientele includes a mix of imaging biomarkers market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of global-level data and insights on the Global imaging biomarkers market , including forecasts for subscribers. This global databook contains high-level insights into Global imaging biomarkers market from 2021 to 2033, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Global imaging biomarkers market size, by regions, 2021-2033 (US$M)

Top 10 countries: Imaging biomarkers market size, 2024 (US$M)

Global imaging biomarkers market share, by biomarkers, 2024 & 2033 (%, US$M)

Imaging biomarkers market: Opportunity assessment by country

Global imaging biomarkers market, by region, 2024 (US$M)

Global imaging biomarkers market size, by regions, 2021-2033 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online